Molecular markers for urothelial bladder cancer prognosis: Toward implementation in clinical practice-Reference-Cited by-同舟云学术

Molecular markers for urothelial bladder cancer prognosis: Toward implementation in clinical practice

Published:2014-10 Issue:7 Volume:32 Page:1078-1087
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

van Rhijn Bas W.G.,Catto James W.,Goebell Peter J.,Knüchel Ruth,Shariat Shahrokh F.,van der Poel Henk G.,Sanchez-Carbayo Marta,Thalmann George N.,Schmitz-Dräger Bernd J.,Kiemeney Lambertus A.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference66 articles.

1. Cancer incidence, mortality and prevalence worldwide in 2012;GLOBOCAN,2012

2. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials;Sylvester;Eur Urol,2006

3. Recurrence and progression of disease in non–muscle-invasive bladder cancer: from epidemiology to treatment strategy;Van Rhijn;Eur Urol,2009

4. EAU guidelines on non–muscle invasive urothelial carcinoma of the bladder—update 2013;Babjuk;Eur Urol,2013

5. The health economics of bladder cancer;Botteman;Pharmacoeconomics,2003

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-Metastatic Effect of Pyruvate Dehydrogenase Kinase 4 Inhibition in Bladder Cancer via the ERK, SRC, and JNK Pathways;International Journal of Molecular Sciences;2022-10-31

2. The Search for the Optimal cut-off Value of p53-Immunohistochemistry to Predict Prognosis of Invasive Bladder Cancer: A Multi-Center, Multi-Laboratory Analysis;International Journal of Surgical Pathology;2022-04-24

3. Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients;Urologic Oncology: Seminars and Original Investigations;2021-12

4. High-Risk Nonmuscle Invasive Bladder Cancer: Selecting the Appropriate Patient for Timely Cystectomy;Urology;2021-01

5. Non-muscle Invasive Bladder Cancer: Identifying Patients to Consider Timely, Initial Cystectomy;The Bulletin of Urooncology;2020-12-01